150 related articles for article (PubMed ID: 7741989)
1. Markers supplementing CA 125 in ovarian cancer.
Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
[TBL] [Abstract][Full Text] [Related]
2. Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
Mogensen O; Mogensen B; Jakobsen A
Br J Cancer; 1990 Feb; 61(2):327-9. PubMed ID: 2310684
[TBL] [Abstract][Full Text] [Related]
3. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
Halila H; Lehtovirta P; Stenman UH
Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
[TBL] [Abstract][Full Text] [Related]
4. TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.
Medl M; Ogris E; Peters-Engl C; Leodolter S
Br J Cancer; 1995 May; 71(5):1051-4. PubMed ID: 7734298
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA125) in patients with epithelial ovarian cancer.
Peters-Engl C; Medl M; Ogris E; Leodolter S
Anticancer Res; 1995; 15(6B):2727-30. PubMed ID: 8669854
[TBL] [Abstract][Full Text] [Related]
6. [Clinical relevance of tumor markers in epithelial ovarian cancer].
Holubec L; Fínek J; Topolcan O; Bouda J; Rokyta Z
Ceska Gynekol; 2004 May; 69(3):225-8. PubMed ID: 15309999
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers in the management of patients with ovarian cancer.
Tuxen MK; Sölétormos G; Dombernowsky P
Cancer Treat Rev; 1995 May; 21(3):215-45. PubMed ID: 7656266
[No Abstract] [Full Text] [Related]
8. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
[TBL] [Abstract][Full Text] [Related]
9. Serum markers as prognostic factors in epithelial ovarian cancer: an overview.
Maggino T; Gadducci A
Eur J Gynaecol Oncol; 2000; 21(1):64-9. PubMed ID: 10726623
[TBL] [Abstract][Full Text] [Related]
10. New technologies for the identification of markers for early detection of ovarian cancer.
Bandera CA; Ye B; Mok SC
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):51-5. PubMed ID: 12544502
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.
Venesmaa P; Lehtovirta P; Stenman UH; Leminen A; Forss M; Ylikorkala O
Br J Cancer; 1994 Dec; 70(6):1188-90. PubMed ID: 7981075
[TBL] [Abstract][Full Text] [Related]
12. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
13. Limitations to the use of the CA-125 antigen level in ovarian cancer.
Markman M
Curr Oncol Rep; 2003 Jul; 5(4):263-4. PubMed ID: 12781066
[No Abstract] [Full Text] [Related]
14. The role of ultrasound and tumour markers in the early detection of ovarian cancer.
Oram DH; Jeyarajah AR
Br J Obstet Gynaecol; 1994 Nov; 101(11):939-45. PubMed ID: 7999723
[No Abstract] [Full Text] [Related]
15. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
17. Early detection of ovarian cancer: promise and reality.
Bast RC; Urban N; Shridhar V; Smith D; Zhang Z; Skates S; Lu K; Liu J; Fishman D; Mills G
Cancer Treat Res; 2002; 107():61-97. PubMed ID: 11775462
[No Abstract] [Full Text] [Related]
18. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer.
Ind T; Iles R; Shepherd J; Chard T
Br J Obstet Gynaecol; 1997 Sep; 104(9):1024-9. PubMed ID: 9307529
[TBL] [Abstract][Full Text] [Related]
20. CA 125 in biological fluids.
Molina R; Filella X; Jo J; Agusti C; Ballesta AM
Int J Biol Markers; 1998; 13(4):224-30. PubMed ID: 10228906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
